<DOC>
	<DOCNO>NCT00330499</DOCNO>
	<brief_summary>The purpose study define optimal management localise transitional cell carcinoma ( TCC ) urinary bladder . The main objective evaluate whether chemoradiation superior radiotherapy alone .</brief_summary>
	<brief_title>Efficacy Study Adding Chemotherapy Radiotherapy Treating Bladder Cancer .</brief_title>
	<detailed_description>Whilst concurrent chemo-radiation increasingly look upon treatment choice patient refer bladder preservation , study NCI Canada ( Coppin CM , Gospodarowicz MK et al.Improved Local Control Invasive Bladder Cancer Concurrent Cisplatin Pre-operative Definitive Radiation.J . Clinical Oncol . 14 ( 11 ) : 2901-2907 , 1996 ) randomise trial show superiority concurrent Cisplatin radiation treatment radiation alone increase pelvic tumour control . There impact overall survival . However , study relatively small subject number include two distinct treatment option . In one group patient treat bladder spar approach pre-operative therapy cystectomy type definitive treatment decide upon treat Specialist patient . At 5 year pelvic failure rate radiation alone chemo-radiation arm 59 % 40 % respectively . With half patient group plan cystectomy part treatment regimen , rate local relapse ( especially chemo-radiation arm ) disappointing . Given concern study , continue paucity randomise phase III study compare chemo-radiation radiation alone , lie opportunity Australasian centre take challenge . For study , propose schedule chemo-radiation arm investigate previous phase II study ( six weekly dos Cisplatin plus radiation dose 64Gy 32 fraction 6.5 week ) . This compare radical radiation alone ( 64Gy 32 fraction 6.5 week ) .</detailed_description>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically proven TCC urinary bladder . Mixed tumour comprise predominantly TCC element squamous adenomatous metaplasia carcinoma also eligible . Clinically radiologically localise T2 , T3 T4a nonbulky disease ( &lt; = 7cm maximum dimension ) , N0 , M0 . If radiological evaluation lymph node interpret `` positive '' must evaluate either lymph node sample percutaneous needle biopsy . Patients histologically confirm lymph node metastasis eligible . Maximal TUR . N.B . Previous : 1. partial cystectomy ; 2. endoscopic resection bladder tumour/s ; 3. intravesical chemotherapy ; 4. intravesical BCG exclude patient eligible . However , patient adequate functioning bladder ( clarified refer Urologist need void volume measure ) . Creatinine clearance &gt; = 50ml/minute calculation measurement . A white blood cell count &gt; = 3.5 x 10^9/L absolute neutrophil count &gt; = 1.5 x 10^9/L platelet count &gt; = 100 x 10^9/L . ECOG status 0 , 1 2 . No age limit applies provide patient mentally , physically geographically capable undergoing treatment followup . No significant intercurrent morbidity . Pure squamous carcinoma adenocarcinoma . Extensive multifocal CIS change bladder . T3 T4a tumours unsuitable curative treatment ( i.e . &gt; 7cm dimension ) , T4b , node positive metastatic disease . Presence ureteric obstruction due tumour infiltration UO amenable stenting . Previous radiation treatment pelvis . Previous significant pelvic surgery . Significant bowel gynaecological inflammatory disease . Creatinine clearance &lt; 50ml/minute calculation measurement . A white blood cell count &lt; 3.5 x 10^9/L absolute neutrophil count &lt; 1.5 x 10^9L and/or platelet count &lt; 100 x 10^9/L . Other consideration make patient unfit Cisplatin therapy . Prior concurrent malignancy site unless diseasefree great 5 year , except : 1. nonmelanoma skin cancer , and/or 2 . ( ) Stage T1 well differentiate prostatic carcinoma men , In situ carcinoma cervix woman . Bladder tumour biopsy . These patient must refer back adequate resection else include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Locally invasive</keyword>
	<keyword>Bladder cancer</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Organ conservation</keyword>
</DOC>